Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

100 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Screening for liver fibrosis by using a noninvasive biomarker in patients with diabetes.
Jacqueminet S, Lebray P, Morra R, Munteanu M, Devers L, Messous D, Bernard M, Hartemann-Heurtier A, Imbert-Bismut F, Ratziu V, Grimaldi A, Poynard T. Jacqueminet S, et al. Clin Gastroenterol Hepatol. 2008 Jul;6(7):828-31. doi: 10.1016/j.cgh.2008.03.005. Epub 2008 Jun 4. Clin Gastroenterol Hepatol. 2008. PMID: 18524692
Clinico-biological markers for the prognosis of status epilepticus in adults.
Hanin A, Demeret S, Lambrecq V, Rohaut B, Marois C, Bouguerra M, Demoule A, Beaudeux JL, Bittar R, Denis JA, Imbert-Bismut F, Lamari F, Rucheton B, Bonnefont-Rousselot D, Chavez M, Navarro V. Hanin A, et al. Among authors: imbert bismut f. J Neurol. 2022 Nov;269(11):5868-5882. doi: 10.1007/s00415-022-11199-4. Epub 2022 Jun 29. J Neurol. 2022. PMID: 35768546
Real time identification of drug-induced liver injury (DILI) through daily screening of ALT results: a prospective pilot cohort study.
M'Kada H, Perazzo H, Munteanu M, Ngo Y, Ramanujam N, Fautrel B, Imbert-Bismut F, Ratziu V, Schuppe-Koistinen I, Leblond V, Delattre JY, Samson Y, Caen OL, Bricaire F, Khayat D, Pierrot-Deseilligny C, Herson S, Amoura Z, Tilleul P, Deckmyn O, Coriat P, Delpech VN, Boulogne P, Bonnefont-Rousselot D, Poynard T; Drug Induced Liver Injury Groupe Hospitalier Pitié-Salpêtrière Group; Safer and Faster Evidence-based Translation Consortium. M'Kada H, et al. PLoS One. 2012;7(8):e42418. doi: 10.1371/journal.pone.0042418. Epub 2012 Aug 14. PLoS One. 2012. PMID: 22905129 Free PMC article.
Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease.
Poynard T, Ratziu V, Charlotte F, Messous D, Munteanu M, Imbert-Bismut F, Massard J, Bonyhay L, Tahiri M, Thabut D, Cadranel JF, Le Bail B, de Ledinghen V; LIDO Study Group; CYTOL study group. Poynard T, et al. BMC Gastroenterol. 2006 Nov 10;6:34. doi: 10.1186/1471-230X-6-34. BMC Gastroenterol. 2006. PMID: 17096854 Free PMC article.
Diagnostic value of serum protein profiling by SELDI-TOF ProteinChip compared with a biochemical marker, FibroTest, for the diagnosis of advanced fibrosis in patients with chronic hepatitis C.
Morra R, Munteanu M, Bedossa P, Dargere D, Janneau JL, Paradis V, Ratziu V, Charlotte F, Thibault V, Imbert-Bismut F, Poynard T. Morra R, et al. Aliment Pharmacol Ther. 2007 Sep 15;26(6):847-58. doi: 10.1111/j.1365-2036.2007.03427.x. Aliment Pharmacol Ther. 2007. PMID: 17767469
100 results